dx 8951 has been researched along with Fibrosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masubuchi, N | 1 |
| Atsumi, R; Iwasaki, D; Morikawa, H; Oguma, T | 1 |
| Kuga, H; Kumazawa, E; Ochi, Y; Shiose, Y | 1 |
3 other study(ies) available for dx 8951 and Fibrosarcoma
| Article | Year |
|---|---|
Pharmacokinetics of DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f, in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Camptothecin; Drug Carriers; Fibrosarcoma; Half-Life; Injections, Intravenous; Mice; Mice, Inbred BALB C; Neoplasm Transplantation | 2004 |
Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tan
Topics: Animals; Atmospheric Pressure; Camptothecin; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Fibrosarcoma; Freezing; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Reproducibility of Results; Sensitivity and Specificity | 2005 |
A possible mechanism for the long-lasting antitumor effect of the macromolecular conjugate DE-310: mediation by cellular uptake and drug release of its active camptothecin analog DX-8951.
Topics: Animals; Antineoplastic Agents; Ascites; Camptothecin; Chromatography, High Pressure Liquid; Endocytosis; Fibrosarcoma; Fluorescence; Injections, Intraperitoneal; Lysosomes; Macrophages; Mice; Microscopy, Confocal; Neoplasm Transplantation; Tumor Cells, Cultured | 2005 |